ATE120468T1 - Hemmer der proteasen von retroviren. - Google Patents

Hemmer der proteasen von retroviren.

Info

Publication number
ATE120468T1
ATE120468T1 AT90870034T AT90870034T ATE120468T1 AT E120468 T1 ATE120468 T1 AT E120468T1 AT 90870034 T AT90870034 T AT 90870034T AT 90870034 T AT90870034 T AT 90870034T AT E120468 T1 ATE120468 T1 AT E120468T1
Authority
AT
Austria
Prior art keywords
inhibitors
retroviruses
proteases
protease
peptides
Prior art date
Application number
AT90870034T
Other languages
English (en)
Inventor
Garland Rose Marshall
Mihaly Vadkerti Toth
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Application granted granted Critical
Publication of ATE120468T1 publication Critical patent/ATE120468T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02Linear peptides containing at least one abnormal peptide link
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16211Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT90870034T 1989-03-08 1990-03-07 Hemmer der proteasen von retroviren. ATE120468T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/320,742 US5342922A (en) 1989-03-08 1989-03-08 Inhibitors of retroviral protease

Publications (1)

Publication Number Publication Date
ATE120468T1 true ATE120468T1 (de) 1995-04-15

Family

ID=23247697

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90870034T ATE120468T1 (de) 1989-03-08 1990-03-07 Hemmer der proteasen von retroviren.

Country Status (6)

Country Link
US (2) US5342922A (de)
EP (1) EP0387231B1 (de)
AT (1) ATE120468T1 (de)
DE (1) DE69018113T2 (de)
DK (1) DK0387231T3 (de)
ES (1) ES2070309T3 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5086165A (en) * 1989-03-08 1992-02-04 Washington University Inhibitors of retroviral protease with a ketomethylene isosteric replaced amide bond
US5212157A (en) * 1989-06-06 1993-05-18 Bio-Mega, Inc. Enzyme inhibitors
US6313094B1 (en) 1990-12-11 2001-11-06 Japan Energy Corporation β-amino-α-hydroxycarboxylic acid derivatives and HIV protease inhibitors
US5554728A (en) * 1991-07-23 1996-09-10 Nexstar Pharmaceuticals, Inc. Lipid conjugates of therapeutic peptides and protease inhibitors
US6071895A (en) 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
US5888992A (en) 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
JPH07504654A (ja) 1992-03-11 1995-05-25 ナルヘックス リミテッド オキソ及びヒドロキシ置換炭化水素のアミン誘導体
US5559256A (en) * 1992-07-20 1996-09-24 E. R. Squibb & Sons, Inc. Aminediol protease inhibitors
EP0610745A3 (en) * 1993-02-09 1994-09-28 Miles Inc Novel aminomethylene derivatives as immunosuppressants.
ATE172985T1 (de) * 1993-02-09 1998-11-15 Bayer Ag Sulfonamidaminomethylenderivate als immunsuppressiva
US5686469A (en) * 1993-02-09 1997-11-11 Miles Inc. Aminomethylene derivaties as immunosuppressants
DE4332395A1 (de) * 1993-09-23 1995-04-13 Horst Dr Lindhofer Inhibitoren zur Hemmung der zymogenähnlichen Freispaltung der HIV-1 Protease
IL111991A (en) * 1994-01-28 2000-07-26 Abbott Lab Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent
DE4412174A1 (de) * 1994-04-08 1995-10-19 Schramm Wolfgang Prof Dr Peptide, Verfahren zu ihrer Herstellung und ihre Verwendung
US6222043B1 (en) 1995-06-30 2001-04-24 Japan Energy Corporation Methods of preparing novel dipeptide compounds or pharmaceutically acceptable salts thereof
CA2179935C (en) * 1995-06-30 2010-09-07 Ryohei Kato Novel dipeptide compound or pharmaceutically acceptable salt thereof and medical use thereof
JP3098401B2 (ja) * 1995-07-12 2000-10-16 株式会社エルティーティー研究所 経鼻投与用製剤
US5872210A (en) * 1995-10-05 1999-02-16 The United States Of America As Represented By The Department Of Health And Human Services Transframe peptide inhibitor of viral protease
US5747526A (en) * 1996-01-25 1998-05-05 Hollinshead; Ariel C. Anti-HIV /Aids Chemo(C)-, immuno(I)-, or ci-therapy using tur (or related compounds) and/or NVA (or EPV)
JP3020141B2 (ja) * 1996-10-07 2000-03-15 株式会社富士薬品 経鼻投与用製剤
EP0900566A4 (de) 1996-12-27 2001-04-25 Japan Energy Corp Neuartige tripeptidvebindungen und arzneimittel gegen aids
AU750822B2 (en) * 1998-04-03 2002-08-01 Triangle Pharmaceuticals, Inc. Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens
US7141593B1 (en) 1999-06-04 2006-11-28 Abbott Laboratories Pharmaceutical formulations
US7447643B1 (en) 2000-09-21 2008-11-04 Theradoc.Com, Inc. Systems and methods for communicating between a decision-support system and one or more mobile information devices
WO2005016364A1 (en) * 2003-08-14 2005-02-24 Guthy-Renker Corporation Skin care composition including hexapeptide complexes and methods of their manufacture
US20060198800A1 (en) * 2003-08-14 2006-09-07 Natalie Dilallo Skin care compositions including hexapeptide complexes and methods of their manufacture
US20090291884A1 (en) * 2006-11-02 2009-11-26 Michael Agadjanyan Proteins for use in diagnosing and treating infection and disease
FR2959992A1 (fr) * 2010-05-11 2011-11-18 Univ Claude Bernard Lyon Peptides a activite antiproteasique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880779A (en) * 1987-07-31 1989-11-14 Research Corporation Technologies, Inc. Method of prevention or treatment of AIDS by inhibition of human immunodeficiency virus
IL90872A0 (en) * 1988-07-08 1990-02-09 Smithkline Beckman Corp Retroviral protease binding peptides

Also Published As

Publication number Publication date
EP0387231A2 (de) 1990-09-12
US5342922A (en) 1994-08-30
DK0387231T3 (da) 1995-07-03
US6121417A (en) 2000-09-19
DE69018113T2 (de) 1995-09-28
ES2070309T3 (es) 1995-06-01
DE69018113D1 (de) 1995-05-04
EP0387231A3 (de) 1991-05-02
EP0387231B1 (de) 1995-03-29

Similar Documents

Publication Publication Date Title
ATE120468T1 (de) Hemmer der proteasen von retroviren.
ATE293127T1 (de) Synthetische peptidinhibitoren der hiv- übertragung
DE69220100D1 (de) Retrovirale Protease-Inhibitoren
EA199700221A1 (ru) Замещенный аминокислотой гидроксиэтиламиносульфонамид в качестве ингибиторов ретровирусной протеазы
ATE308558T1 (de) Hiv-1- und hiv-2-peptide zur hemmung von mit membranfusionen in zusammenhang stehenden phänomenen, einschliesslich der übertragung von hiv
EA199700331A1 (ru) Тгф-содержащие сульфонамидные ингибиторы аспартил-протеазы
ATE377006T1 (de) Aus d-aminosäuren abgeleitete cystein- und serinproteasehemmer
DK0542931T3 (da) Serinproteasevarianter med peptidligaseaktivitet
DK3688D0 (da) Pankreatisk sekretorisk trypsininhibitor og varianter deraf fremstillet af en rekombinant vaert, fremgangsmaade, ekspressionsvektor og rekombinant vaert samt farmaceutisk anvendelse deraf
ATE309264T1 (de) Peptidyl-2-amino-1hydroxyalkansulfonsäuren als cystein-protease-inhibitoren
FI915004A0 (fi) Nytt proteas.
DE69715181D1 (de) Peptid der löslichen form von acetylcholinesterase mit aktivität als calciumkanalmodulator
ATE113597T1 (de) Antagonisten von excitatorischen aminosäuren.
ATE146188T1 (de) Substituierungsanaloge von magaininpeptiden
DE69002950D1 (de) Peptide mit diaminoglycolen als übergangszustandmimik.
KR890004724A (ko) 신규 프로테아제 제제(製劑)
EP0238473A3 (de) Serinprotease-Hemmungsstoffe
DE3852105D1 (de) Verfahren zur herstellung von aprotinin und aprotinin-homologen in hefe.
DK0541753T3 (da) Hidtil ukendt hybrid, opløselig og ikke-spaltelig gp160-variant
ES2023746A6 (es) Procedimiento de preparacion de peptidos de serina-acido aspartico- lisina
EP0233721A3 (de) Zusammensetzungen zur Entfernung von Proteinverunreinigungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee